CME Group Inc. (NASDAQ:CME) Receives $236.13 Consensus PT from Analysts

Shares of CME Group Inc. (NASDAQ:CMEGet Free Report) have been assigned an average recommendation of “Reduce” from the fifteen ratings firms that are covering the firm, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a sell recommendation, eight have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $238.93.

A number of research analysts have commented on CME shares. Citigroup cut CME Group from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $255.00 to $250.00 in a research note on Monday, January 6th. JPMorgan Chase & Co. upped their price target on CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a research note on Thursday, February 13th. Barclays increased their price objective on CME Group from $257.00 to $263.00 and gave the company an “equal weight” rating in a research note on Thursday, February 13th. Royal Bank of Canada increased their price objective on CME Group from $235.00 to $269.00 and gave the company a “sector perform” rating in a research note on Thursday, February 13th. Finally, Morgan Stanley increased their price objective on CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 19th.

Read Our Latest Research Report on CME Group

Insiders Place Their Bets

In related news, COO Suzanne Sprague sold 1,500 shares of the firm’s stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $256.83, for a total transaction of $385,245.00. Following the transaction, the chief operating officer now owns 8,036 shares of the company’s stock, valued at $2,063,885.88. This trade represents a 15.73 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Hilda Harris Piell sold 3,984 shares of the firm’s stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $250.47, for a total value of $997,872.48. Following the transaction, the insider now directly owns 27,046 shares in the company, valued at approximately $6,774,211.62. This represents a 12.84 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 17,076 shares of company stock valued at $4,271,496. 0.30% of the stock is currently owned by insiders.

Hedge Funds Weigh In On CME Group

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Lake Street Advisors Group LLC boosted its holdings in CME Group by 108.7% in the 4th quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider’s stock valued at $2,949,000 after purchasing an additional 6,453 shares in the last quarter. Meyer Handelman Co. purchased a new stake in CME Group in the 4th quarter valued at approximately $6,144,000. Spire Wealth Management boosted its holdings in CME Group by 37.4% in the 4th quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider’s stock valued at $307,000 after purchasing an additional 359 shares in the last quarter. AEGON ASSET MANAGEMENT UK Plc boosted its holdings in CME Group by 19.3% in the 4th quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider’s stock valued at $75,730,000 after purchasing an additional 52,862 shares in the last quarter. Finally, Bank of Montreal Can boosted its holdings in CME Group by 41.8% in the 3rd quarter. Bank of Montreal Can now owns 1,028,090 shares of the financial services provider’s stock valued at $224,432,000 after purchasing an additional 303,169 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Down 0.7 %

NASDAQ:CME opened at $260.43 on Wednesday. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The stock’s fifty day moving average is $241.25 and its two-hundred day moving average is $231.60. CME Group has a 52 week low of $190.70 and a 52 week high of $263.65. The stock has a market capitalization of $93.85 billion, a price-to-earnings ratio of 26.93, a price-to-earnings-growth ratio of 6.76 and a beta of 0.53.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, topping analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. Research analysts anticipate that CME Group will post 10.49 EPS for the current year.

CME Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be paid a $1.25 dividend. The ex-dividend date of this dividend is Friday, March 7th. This is a boost from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a yield of 1.92%. CME Group’s dividend payout ratio (DPR) is currently 51.71%.

CME Group declared that its Board of Directors has initiated a stock repurchase program on Thursday, December 5th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the financial services provider to reacquire up to 3.4% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s board believes its stock is undervalued.

CME Group Company Profile

(Get Free Report

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.